Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Invernizzi

Showing results (341-350 of 420) with videos related to

Pageof 42
Sort By:
Journal of Hepatology|April 14, 2019
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitisMaren H Harms, Henk R van Buuren, Christophe Corpechot, et al.
Journal of Autoimmunity|October 12, 2010
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosisHaiying Liu, Gary L Norman, Zakera Shums, et al.
Gut|January 9, 2015
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international studyPalak J Trivedi, Willem J Lammers, Henk R van Buuren, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2021
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinomaMargherita Correnti, Andrea Cappon, Mirella Pastore, et al.
The American Journal of Pathology|July 28, 2019
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic CholangiocarcinomaChiara Raggi, Karim Fiaccadori, Mirella Pastore, et al.
Frontiers in Immunology|April 16, 2014
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosisCarlo Selmi, Francesca Cavaciocchi, Ana Lleo, et al.
European Journal of Internal Medicine|June 11, 2023
Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH GroupNikolaos K Gatselis, Kalliopi Zachou, Aldo J Montano Loza, et al.
Nature Communications|September 23, 2015
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathwaysHeather J Cordell, Younghun Han, George F Mells, et al.
Nature Reviews. Gastroenterology & Hepatology|April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
Gut|December 18, 2019
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitisMaren H Harms, Rozanne C de Veer, Willem J Lammers, et al.
Pageof 42

Showing results (341-350 of 420) with videos related to

Sort By:
Pageof 42
Journal of Hepatology|April 14, 2019
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitisMaren H Harms, Henk R van Buuren, Christophe Corpechot, et al.
Journal of Autoimmunity|October 12, 2010
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosisHaiying Liu, Gary L Norman, Zakera Shums, et al.
Gut|January 9, 2015
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international studyPalak J Trivedi, Willem J Lammers, Henk R van Buuren, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2021
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinomaMargherita Correnti, Andrea Cappon, Mirella Pastore, et al.
The American Journal of Pathology|July 28, 2019
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic CholangiocarcinomaChiara Raggi, Karim Fiaccadori, Mirella Pastore, et al.
Frontiers in Immunology|April 16, 2014
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosisCarlo Selmi, Francesca Cavaciocchi, Ana Lleo, et al.
European Journal of Internal Medicine|June 11, 2023
Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH GroupNikolaos K Gatselis, Kalliopi Zachou, Aldo J Montano Loza, et al.
Nature Communications|September 23, 2015
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathwaysHeather J Cordell, Younghun Han, George F Mells, et al.
Nature Reviews. Gastroenterology & Hepatology|April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
Gut|December 18, 2019
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitisMaren H Harms, Rozanne C de Veer, Willem J Lammers, et al.
Pageof 42